Peter Salzmann is of Corbus Pharmaceuticals Holdings, Inc.. Currently has a direct ownership of 2,783 shares of CRBP, which is worth approximately $45,585. The most recent transaction as insider was on May 30, 2024, when has been sold 2,783 shares (Common Stock, par value $0.0001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.78K
0% 3M change
n/a 12M change
Total Value Held $45,585

Peter Salzmann Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 30 2024
BUY
Grant, award, or other acquisition
-
2,783 Added 50.0%
2,783 Common Stock, par valu...

Also insider at

IMVT
Immunovant, Inc. Healthcare
PS

Peter Salzmann

New York, NY

Track Institutional and Insider Activities on CRBP

Follow Corbus Pharmaceuticals Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRBP shares.

Notify only if

Insider Trading

Get notified when an Corbus Pharmaceuticals Holdings, Inc. insider buys or sells CRBP shares.

Notify only if

News

Receive news related to Corbus Pharmaceuticals Holdings, Inc.

Track Activities on CRBP